Illness	Number of cases
Essential primary hypertension (I10.01)	109
Left ventricular failure unspecified (I50.13)	73
Diarrhoea and gastroenteritis of presumed infectious origin (A09.0)	65
Volume depletion (E86)	62
Pain in throat and chest (R07.4)	49
Pneumonia organism unspecified - Bronchopneumonia unspecified organism (J18.0)	47
Atrial fibrillation and flutter - Paroxysmal atrial fibrillation (I48.0)	45
Dizziness and giddiness (R42)	37
Left ventricular failure unspecified (I50.12)	35
Left ventricular failure unspecified (I50.14)	33

Top 10 treatments

Treatment	Number
Computed tomography (CT) of the head without contrast medium (3-200)	397
(9-984.7)	295
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	279
(9-984.8)	259
Examination of the oesophagus, stomach and duodenum by endoscopy (1-632.0)	244
Measurement of lung function in an airtight cabin - whole body plethysmography (1-710)	222
Analysis of the amount of carbon monoxide taken in and given off by the lungs (1-711)	169
Complex differential diagnostic sonography of the vascular system with quantitative evaluation (3-035)	169
(9-984.6)	125
Computed tomography of the pelvis with contrast medium (3-226)	120

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0100 , 0800

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ28

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
40	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
34	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
26	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility